AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 177 filers reported holding AXSOME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,394,852 | -2.7% | 248,889 | +0.0% | 0.23% | 0.0% |
| Q2 2023 | $17,876,756 | +74.1% | 248,772 | +49.4% | 0.23% | +56.9% |
| Q1 2023 | $10,270,028 | -42.9% | 166,505 | -28.6% | 0.14% | -46.3% |
| Q4 2022 | $17,978,617 | -9.4% | 233,095 | -3.4% | 0.27% | -44.5% |
| Q2 2020 | $19,853,000 | +28.5% | 241,284 | -8.1% | 0.48% | -6.4% |
| Q1 2020 | $15,445,000 | -45.8% | 262,541 | -4.8% | 0.52% | -31.9% |
| Q4 2019 | $28,498,000 | – | 275,717 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |